Autonomous Synthesis Robot Uses AI to Speed Up Chemical Discovery

Chemists of the University of Amsterdam (UvA) have developed an autonomous chemical synthesis robot with an integrated AI-driven machine learning unit. Dubbed 'RoboChem', the benchtop device can outperform a human chemist in terms of speed and accuracy while also displaying a high level of ingenuity. As the first of its kind, it could significantly accelerate chemical discovery of molecules for pharmaceutical and many other applications. RoboChem's first results were published on 25 January in the journal Science.

RoboChem was developed by the group of Prof. Timothy Noël at the UvA's Van't Hoff Institute for Molecular Sciences. Their paper shows that RoboChem is a precise and reliable chemist that can perform a variety of reactions while producing minimal amounts of waste. Working autonomously around the clock, the system delivers results quickly and tirelessly. Noël: "In a week, we can optimise the synthesis of about ten to twenty molecules. This would take a PhD student several months." The robot not only yields the best reaction conditions, but also provides the settings for scale-up. "This means we can produce quantities that are directly relevant for suppliers to the pharmaceutical industry, for example."

The expertise of the Noël group is in flow chemistry, a novel way of performing chemistry where a system of small, flexible tubes replaces beakers, flasks and other traditional chemistry tools. In RoboChem, a robotic needle carefully collects starting materials and mixes these together in small volumes of just over half a millilitre. These then flow through the tubing system towards the reactor. There, the light from powerful LEDs triggers the molecular conversion by activating a photocatalyst included in the reaction mixture. The flow then continues towards an automated NMR spectrometer that identifies the transformed molecules. These data are fed back in real-time to the computer that controls RoboChem. "This is the brain behind RoboChem," says Noël. "It processes the information using artificial intelligence. We use a machine learning algorithm that autonomously determines which reactions to perform. It always aims for the optimal outcome and constantly refines its understanding of the chemistry."

The group put a lot of effort into substantiating RoboChem's results. All of the molecules now included in the Science paper were isolated and checked manually. Noël says the system has impressed him with its ingenuity: "I have been working on photocatalysis for more than a decade now. Still, RoboChem has shown results that I would not have been able to predict. For instance, it has identified reactions that require only very little light. At times I had to scratch my head to fathom what it had done. You then wonder: would we have done it the same way? In retrospect, you see RoboChem's logic. But I doubt if we would have obtained the same results ourselves. Or not as quickly, at least."

The researchers also used RoboChem to replicate previous research published in four randomly selected papers. They then determined whether Robochem produced the same - or better - results. "In about 80% of the cases, the system produced better yields. For the other 20%, the results were similar," Noël says. "This leaves me with no doubt that an AI-assisted approach will be beneficial to chemical discovery in the broadest possible sense."

According to Noël, the relevance of RoboChem and other 'computerised' chemistry also lies in the generation of high-quality data, which will benefit the future use of AI. "In traditional chemical discovery only a few molecules are thoroughly researched. Results are then extrapolated to seemingly similar molecules. RoboChem produces a complete and comprehensive dataset where all relevant parameters are obtained for each individual molecule. That provides much more insight."

Another feature is that the system also records 'negative' data. In current scientific practice, most published data only reflects successful experiments. "A failed experiment also provides relevant data," says Noël. "But this can only be found in the researchers' handwritten lab notes. These are not published and thus unavailable for AI-powered chemistry. RoboChem will change that, too. I have no doubt that if you want to make breakthroughs in chemistry with AI, you will need these kinds of robots."

Slattery A, Wen Z, Tenblad P, Sanjosé-Orduna J, Pintossi D, den Hartog T, Noël T.
Automated self-optimization, intensification, and scale-up of photocatalysis in flow.
Science. 2024 Jan 26;383(6681):eadj1817. doi: 10.1126/science.adj1817

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...